273 related articles for article (PubMed ID: 34126278)
21. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
22. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
[TBL] [Abstract][Full Text] [Related]
23. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans.
Taghavi S; Krenn K; Jaksch P; Klepetko W; Aharinejad S
Am J Transplant; 2005 Jun; 5(6):1548-52. PubMed ID: 15888067
[TBL] [Abstract][Full Text] [Related]
24. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
Chien JW; Duncan S; Williams KM; Pavletic SZ
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
[TBL] [Abstract][Full Text] [Related]
25. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
[TBL] [Abstract][Full Text] [Related]
27. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of bronchiolitis obliterans syndrome after haplo- hematopoietic stem cell transplantation].
Zhuang J; Gu B; Ke P; Liu YJ; Wu XJ; Xue SL; Hu XH; He XF; Ma X; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):404-410. PubMed ID: 31207706
[No Abstract] [Full Text] [Related]
29. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
[TBL] [Abstract][Full Text] [Related]
30. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation.
Duque-Afonso J; Ihorst G; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Prasse A; Marks R
Bone Marrow Transplant; 2013 Aug; 48(8):1098-103. PubMed ID: 23376822
[TBL] [Abstract][Full Text] [Related]
31. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
[TBL] [Abstract][Full Text] [Related]
32. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
[TBL] [Abstract][Full Text] [Related]
33. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Cheng GS; Bondeelle L; Gooley T; He Q; Jamani K; Krakow EF; Flowers MED; de Latour RP; Michonneau D; Socié G; Chien JW; Chevret S; Bergeron A
Biol Blood Marrow Transplant; 2020 Feb; 26(2):392-400. PubMed ID: 31682980
[TBL] [Abstract][Full Text] [Related]
34. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
[TBL] [Abstract][Full Text] [Related]
35. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Cheng GS; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J; Nazareno R; Bloye K; Johnson TD; Remberger M; Mattsson J; Vummidi D; Kazerooni EE; Lama VN; Galban S; Boeckh M; Yanik GA; Galban CJ
Am J Transplant; 2020 Aug; 20(8):2198-2205. PubMed ID: 32034974
[TBL] [Abstract][Full Text] [Related]
36. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
[TBL] [Abstract][Full Text] [Related]
37. Early and rapid development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.
Dickey JS; Dickey BF; Alousi AM; Champlin RE; Sheshadri A
Respir Med Case Rep; 2024; 49():102001. PubMed ID: 38745870
[TBL] [Abstract][Full Text] [Related]
38. The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndrome.
Banerjee B; Ling KM; Sutanto EN; Musk M; Yerkovich ST; Hopkins PM; Stick SM; Kicic A; Chambers DC
J Heart Lung Transplant; 2011 Oct; 30(10):1175-85. PubMed ID: 21784664
[TBL] [Abstract][Full Text] [Related]
39. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
[TBL] [Abstract][Full Text] [Related]
40. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
Archer G; Berger I; Bondeelle L; de Margerie-Mellon C; Cassonnet S; de Latour RP; Michonneau D; Chevret S; Bergeron A
Bone Marrow Transplant; 2023 Jan; 58(1):87-93. PubMed ID: 36309588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]